ABVC BioPharma, Inc.
ABVC
$0.911
$0.0354.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 50.38% | 4.10% | 87.97% | -23.73% | -75.47% |
| Total Receivables | -5.04% | -4.24% | 41.16% | 18.47% | -34.57% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.37% | -9.42% | -36.84% | 57.86% | -29.35% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -2.70% | 2.26% | -1.59% | -4.28% | 5.75% |
| Total Current Assets | 1.47% | -1.89% | 22.02% | 8.32% | -33.56% |
|
|
|||||
| Total Current Assets | 1.47% | -1.89% | 22.02% | 8.32% | -33.56% |
| Net Property, Plant & Equipment | -86.36% | -1.14% | -1.40% | 527.97% | -84.43% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 26.49% | 0.72% | -0.25% | -30.93% | -13.45% |
| Total Assets | -47.87% | -1.17% | 1.20% | 85.76% | -53.08% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 0.84% | -3.78% | 5.73% | 0.18% | -12.29% |
| Short-term Debt | 31.93% | 8.10% | 1.20% | 10.26% | -31.04% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.09% | 1.08% | 7.28% | -4.33% | 266.87% |
| Total Finance Division Other Current Liabilities | -26.35% | -28.02% | -33.73% | 79.60% | 681.26% |
| Total Other Current Liabilities | -26.35% | -28.02% | -33.73% | 79.60% | 681.26% |
| Total Current Liabilities | 3.83% | -3.56% | -1.28% | 8.71% | 13.78% |
|
|
|||||
| Total Current Liabilities | 3.83% | -3.56% | -1.28% | 8.71% | 13.78% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 31.93% | 8.10% | 1.20% | 10.26% | -31.04% |
| Capital Leases | 66.53% | -37.85% | -28.10% | -21.91% | -19.66% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -15.56% | -7.22% | 27.65% | 0.00% | 280.70% |
| Total Liabilities | 5.13% | -4.73% | -2.41% | 6.77% | -13.27% |
|
|
|||||
| Common Stock & APIC | -9.98% | 0.26% | 1.23% | 16.29% | -8.28% |
| Retained Earnings | 2.27% | -0.27% | -1.46% | -8.28% | -2.79% |
| Treasury Stock & Other | -0.27% | 0.30% | 5.16% | -6.08% | 9.43% |
| Total Common Equity | -85.33% | 0.78% | 6.43% | 401.39% | -82.92% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -85.33% | 0.78% | 6.43% | 401.39% | -82.92% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -32.47% | 18.51% | -52.47% | -1.50% | -684.86% |
| Total Equity | -90.93% | 1.93% | 4.56% | 497.29% | -86.17% |
|
|
|||||